LAV

Biotechnology · Venture Capital
80investments
28exits
$106.5Mraised by its portfolio in 12 months
1,131open roles in its portfolio

Overview

LAV, formerly Lilly Asia Ventures, is a life sciences venture capital firm investing in biotechnology and healthcare companies in China and the United States. It backs companies from early stage through growth, spanning innovative drugs, biologics, medical devices, diagnostics and healthcare services. Founded in 2008 by Yi Shi with Eli Lilly as its original sponsor, LAV now operates independently and is headquartered in Shanghai with offices in Hong Kong and the United States.

Investor profile

Venture capital
Investments
80
17 of them startups
Hiring now
12
1,131 open roles
Deals in 12 months
1
1 as the lead
Rounds in 12 months
2
$106.5M raised
Exits
28
Focusshare of its companies
Health Care 80%Biotechnology 56%Artificial Intelligence 8%Hardware 4%Financial Services 4%Farming & Agriculture 4%
Where its companies are
China 16%United States 10%Germany 1%Denmark 1%Singapore 1%
Stage of its companies
Series B 42%Series C and later 33%Series A 25%
Its companies, the freshest money firstAll 80 investments
QuantX BiosciencesSeries B $85M · 9 mo ago · led a round InhibrxVenture round $200M · 3 yr ago EdiGeneSeries B $62M · 5 yr ago Perfuse TherapeuticsVenture round $9M · 6 yr ago GlaukosVenture round $25M · 8 yr ago Merck & Co.643 roles Agilent Technologies319 roles Legend Biotech52 roles PINS Medical19 roles Geneseeq15 roles Crown Bioscience13 roles Beijing Kawin Technology5 roles
1,131 open roles at 12 of its companies
Hiring fastestroles opened in 30 days
Merck & Co.445 new roles in 30 days Agilent Technologies129 new roles in 30 days Legend Biotech18 new roles in 30 days
Co-investorscompanies they hold together
Qiming Venture Partners 10 shared OrbiMed 6 shared HongShan 5 shared RA Capital Management 5 shared Cowin Capital 5 shared Nextech Invest 4 shared Sofinnova Investments 3 shared F-Prime Capital 3 shared Eight Roads 3 shared NEA 3 shared
Similar investorstheir companies share markets and countries
Taiho Ventures EcoR1 Capital MPM BioImpact Nextech Invest RA Capital Management Sofinnova Investments Foresite Capital Omega Funds
Sources: its portfolio page, read Nov 3; 1 rounds in the press that name it

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
2
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Shanghai China
HQ
Central Hong Kong
Regional office
Our Philosophy
Room 606-7, St George's Building, 2 Ice House Street, Central, Hong Kong
company site